1.646.889.1200|info@lifescipublicrelations.com

CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia

/, video/CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia

CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia

Elad Kedar, CEO of Orasis Pharmaceuticals, provides a company update at OIS@AAO 2018 in Chicago.

By | 2018-11-28T11:56:40-04:00 November 14th, 2018|News, video|Comments Off on CSF-1 drops demonstrate efficacy, safety in clinical studies for treatment of presbyopia

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.